Cathie Wood's ARK ETF published their daily trades for Thursday, November 14th, 2024, showcasing a series of strategic buy and sell actions across various sectors. Leading the day's transactions was the significant purchase of CRISPR Therapeutics AG (NASDAQ:CRSP) shares, with a total of 178,062 shares acquired across the ARKK and ARKG ETFs, amounting to a substantial $8,865,707 investment. This move underscores ARK's growing interest in the gene-editing company, which has seen consistent buying activity in recent days.
Another notable buy was BWX Technologies Inc (NYSE:BWXT), with ARK scooping up 14,779 shares through its ARKQ ETF, translating to an investment of $1,952,453. This purchase aligns with ARK's focus on innovative industrial companies.
On the sell side, ARK divested a significant portion of its holdings in Roblox Corp (NYSE:NYSE:RBLX) and Rocket Lab USA Inc (NASDAQ:RKLB), with sales totaling $8,222,245 and $11,821,003, respectively. These sales may signal a shift in ARK's portfolio strategy or a response to market dynamics.
Other purchases included Archer Aviation Inc (NYSE:NYSE:ACHR), with a combined acquisition of 409,474 shares through ARKQ and ARKX (NYSE:ARKX) ETFs, totaling $1,752,548. Amazon.com Inc (NASDAQ:AMZN) also saw an addition of 28,509 shares across three ETFs, totaling $6,103,777.
Investors may also note the continued interest in aerospace, with buys in Blade Air Mobility Inc (NASDAQ:BLDE) and Joby Aviation Inc (NYSE:NYSE:JOBY), totaling $612,211 and $1,791,676, respectively. Advanced Micro Devices Inc (NASDAQ:AMD) and Aurora Innovation Inc (NASDAQ:AUR) were among the other companies ARK invested in, albeit with smaller dollar values compared to the top trades.
ARK's selling activity was not limited to the larger transactions; smaller sales included Markforged Holding Corp (NYSE:MKFG), Moderna Inc (NASDAQ:BMV:MRNA), and Materialise NV (NASDAQ:MTLS), with total dollar values of $843, $120,478, and $367, respectively.
The daily trade report reveals ARK's tactical adjustments and ongoing commitment to investing in disruptive innovation. Investors keen on ARK's strategies will likely monitor these trades closely, as they may indicate broader trends and shifts within the ETF's investment focus.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.